Robert Mogyoros, DMD
Oral and Maxillofacial Surgery · Elkins Park, PANPI 1407061161
Payments from drug & device makers
What this record shows
This record is dominated by gifts: $11,546 of the $12,094 with a category attached, or 95.5%. Straumann USA LLC accounts for 97.1% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2021 at $11,532 and has fallen 97.6% since, to $274 in 2022. Among oral and maxillofacial surgery clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 23 payments — averaging $525.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Straumann USA LLC$12K
- Biohorizons Implant Systems Inc.$135
- Centrix Inc$75
- Nobel Biocare USA$49
- Biolase, Inc.$41
- Kulzer, LLC$24
- plus $30 from 2 others
What the payments were for
- Food & beverage$5234%
- Education$250%
- Gifts$11,54695%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Straumann USA LLC | 9 | $11,740 |
| Biohorizons Implant Systems Inc. | 6 | $135 |
| Centrix Inc | 1 | $75 |
| Nobel Biocare USA | 2 | $49 |
| Biolase, Inc. | 1 | $41 |
| Kulzer, LLC | 2 | $24 |
| Orapharma, A Division Of Bausch Health US, LLC | 1 | $15 |
| Dentsply Sirona Inc | 1 | $14 |
How this compares
$12,094 in reported general payments places this provider in the 90th percentile of 369 oral and maxillofacial surgery providers in Pennsylvania.
See all oral and maxillofacial surgery providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Chlorhexidine Gluconate | 238 | $828 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 53 | $414 |
| Naproxen | 130 | $370 |
| Amoxicillin | 99 | $254 |
| Clindamycin Hcl | 31 | $140 |
Paid to pharmacies, not to this prescriber.
Other oral and maxillofacial surgery in Elkins Park
- Mark OchsPittsburgh$449K
- Ankur JohriAllentown$98K
- Richard BauerWexford$95K
- Joseph LeonettiPaoli$88K
- Larry CunninghamPitsburgh$83K
- Neeraj PanchalPhiladelphia$73K
- Eric GranquistPhiladelphia$65K
- Michael HartmanMechanicsburg$50K
- Bernard CostelloPittsburgh$44K
- Thomas HelfstStroudsburg$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.